23-valent pneumococcal polysaccharide vaccine (Zhejiang Vacin Biomedicine)

23价肺炎球菌多糖疫苗 （艾美卫信）

Report date: 2023/08/02 20:00:51

Base Information

Drug Name23-valent pneumococcal polysaccharide vaccine (Zhejiang Vacin Biomedicine)
Drug Alias NameN/A
ClassificationVaccines > Vaccine type > Multivalent vaccineVaccines > Biological material > Bacterial vaccineVaccines > Application > Prophylactic vaccine +[4] 
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsOtitis MediaSepsisPneumonia, Pneumococcal +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesAimei Weixin BioPharm (Zhejiang) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAimei Weixin BioPharm (Zhejiang) Co Ltd
Inactive CompaniesN/A
Active IndicationsOtitis MediaSepsisPneumonia, Pneumococcal +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A